Literature DB >> 11477813

[Clinical study of purified xuefu capsule in treating angina pectoris].

X Wang1, K Chen, W Wang.   

Abstract

OBJECTIVE: To study the effect of purified Xuefu Capsule (PXFC) in treating angina pectoris (AP).
METHODS: Fifty-seven patients with AP were randomly divided into two groups. Group A (30 cases) was treated with PXFC and western medicine, and group B(27 cases) with western medicine (isosorbide dinitrate, diltiazem or atenolol) alone.
RESULTS: The total effective rates and ECG ST-T changes of AP were 93.3% and 63.3% respectively in group A. These results were all superior to those of group B (P < 0.05). Moreover, in group A the level of plasma endothelin (ET-1) decreased from 85.09 +/- 37.56 ng/L to 61.19 +/- 4.02 ng/L, and that of calcitonin gene related peptide (CGRP) increased from 58.64 +/- 19.30 ng/L to 88.87 +/- 20.41 ng/L. Comparing with group B, these changes were statistically different (P < 0.01).
CONCLUSIONS: The effects of adding PXFC on conventional treatment with western medicine were better than those of western medicine.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 11477813

Source DB:  PubMed          Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi        ISSN: 1003-5370


  1 in total

Review 1.  Theory of traditional Chinese medicine and therapeutic method of diseases.

Authors:  Ai-Ping Lu; Hong-Wei Jia; Cheng Xiao; Qing-Ping Lu
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.